Evaxion expands AI-Immunology(TM) platform into autoimmune diseases
Evaxion expands AI-Immunology(TM) platform into autoimmune diseases GlobeNewswire January 13, 2026 Evaxion adds autoimmune disease as a third disease area as it expands its therapeutic focus In future, Evaxion's proprietary AI-Immunology(TM) platform will enable the discovery and development of drug candidates targeting cancer, infectious and autoimmune diseases, leveraging its unique scalability Autoimmune diseases represent a […]